Serum tumor markers in bile duct cancer - a review

被引：31
作者：
Grunnet, M. [1 ]
Mau-Sorensen, M. [1 ]
机构：
[1] Danish Natl Hosp, Rigshosp, Dept Oncol, Copenhagen, Denmark
来源：
BIOMARKERS | 2014年 / 19卷 / 06期
关键词：
Bile duct cancer; biomarker; cholangiocarcinoma; diagnosis; prognosis; serum; TOTAL SIALIC-ACID; CARCINOEMBRYONIC ANTIGEN CEA; INTRAHEPATIC CHOLANGIOCARCINOMA; PANCREATIC-CANCER; DETECTING CHOLANGIOCARCINOMA; CLINICAL-SIGNIFICANCE; MUC5AC MUCIN; PROGNOSTIC-FACTOR; NATURAL-HISTORY; GENE-EXPRESSION;
D O I：
10.3109/1354750X.2014.923048
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Context: Bile duct cancer (BDC) is a disease with a very grave prognosis, often diagnosed too late. Objective: The aim of this review is to evaluate available literature on tumor markers in serum from patients with BDC. Methods: Using the search words "serum markers'', "bile duct cancer'', "cholangiocarcinoma'', "biomarker'' and "tumor marker'', a search was carried out. Results: Seventy-five studies were included in the review. Conclusion: CA19-9 is by far the most studied and most promising diagnostic and/or prognostic marker in BDC. But also the different mucins are interesting as new markers of BDC in serum.
引用
收藏
页码：437 / 443
页数：7
相关论文
共 101 条
  • [1] CA 19-9 and survival in advanced and unresectable pancreatic adenocarcinoma and cholangiocarcinoma
    Ali C.W.
    Kaye T.F.
    Adamson D.J.A.
    Tait I.S.
    Polignano F.M.
    Highley M.S.
    [J]. Journal of Gastrointestinal Cancer, 2007, 38 (2-4) : 108 - 114
  • [2] Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009
    Aljiffry, Murad
    Walsh, Mark J.
    Molinari, Michele
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (34) : 4240 - 4262
  • [3] A new mucin antibody/enzyme-linked lectin-sandwich assay of serum MUC5AC mucin for the diagnosis of cholangiocarcinoma
    Bamrungphon, Wichuda
    Prempracha, Nalinee
    Bunchu, Nophawan
    Rangdaeng, Samreung
    Sandhu, Trichak
    Srisukho, Songphol
    Boonla, Chanchai
    Wongkham, Sopit
    [J]. CANCER LETTERS, 2007, 247 (02) : 301 - 308
  • [4] HER2-mediated upregulation of MMP-1 is involved in gastric cancer cell invasion
    Bao, Wei
    Fu, Hai-Jing
    Jia, Lin-Tao
    Zhang, Yong
    Li, Wei
    Jin, Bo-Quan
    Yao, Li-Bo
    Chen, Si-Yi
    Yang, An-Gang
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2010, 499 (1-2) : 49 - 55
  • [5] Clinical value of biliary alkaline phosphatase in non-jaundiced cholangiocarcinoma
    Bhudhisawasdi, V
    Muisuk, K
    Areejitranusorn, P
    Kularbkaew, C
    Khampitak, T
    Saeseow, OT
    Wongkham, S
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2004, 130 (02) : 87 - 92
  • [6] CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis
    Björnsson, E
    Kilander, A
    Olsson, R
    [J]. LIVER, 1999, 19 (06): : 501 - 508
  • [7] Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment
    Blechacz, Boris
    Gores, Gregory J.
    [J]. HEPATOLOGY, 2008, 48 (01) : 308 - 321
  • [8] Prognostic value of serum MUC5AC mucin in patients with cholangiocarcinoma
    Boonla, C
    Wongkham, S
    Sheehan, JK
    Wongkham, C
    Bhudhisawasdi, V
    Tepsiri, N
    Pairojkul, C
    [J]. CANCER, 2003, 98 (07) : 1438 - 1443
  • [9] Developmental mucin gene expression in the gastroduodenal tract and accessory digestive glands. II. Duodenum and liver, gallbladder, and pancreas
    Buisine, MP
    Devisme, L
    Degand, P
    Dieu, MC
    Gosselin, B
    Copin, MC
    Aubert, JP
    Porchet, N
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2000, 48 (12) : 1667 - 1676
  • [10] Cholangiocarcinoma in patients with primary sclerosing cholangitis: A multicenter case-control study
    Chalasani, N
    Baluyut, A
    Ismail, A
    Zaman, A
    Sood, G
    Ghalib, R
    McCashland, TM
    Reddy, KR
    Zervos, X
    Anbari, MA
    Hoen, H
    [J]. HEPATOLOGY, 2000, 31 (01) : 7 - 11
12345678910